Leerink, Piper Sandler and Oppenheimer acted as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AQST:
- Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
- Aquestive Therapeutics Announces Proposed Public Offering of Common Stock
- Aquestive Therapeutics price target raised to $9 from $7 at H.C. Wainwright
- Aquestive Therapeutics price target raised to $10 from $8 at JMP Securities
- Aquestive Therapeutics’ Anaphylm meets endpoints in Phase 3 allergy study